Literature DB >> 30046576

Nonalcoholic fatty liver disease: is the IFNL4 rs368234815 variant protective from liver damage?

Enrico Galmozzi1, Roberta D'Ambrosio1.   

Abstract

Entities:  

Year:  2018        PMID： 30046576      PMCID： PMC6036062          DOI： 10.21037/hbsn.2018.03.06

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

1.  Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.

Authors:  Kitt Falk Petersen; Sylvie Dufour; Jing Feng; Douglas Befroy; James Dziura; Chiara Dalla Man; Claudio Cobelli; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-17       Impact factor: 11.205

2.  USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.

Authors:  Shimin An; Ling-Ping Zhao; Li-Jun Shen; Siyuan Wang; Kuo Zhang; Yu Qi; Jilin Zheng; Xiao-Jing Zhang; Xue-Yong Zhu; Rong Bao; Ling Yang; Yue-Xin Lu; Zhi-Gang She; Yi-Da Tang
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

3.  IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.

Authors:  Pierre-Yves Bochud; Stéphanie Bibert; Zoltán Kutalik; Etienne Patin; Julien Guergnon; Bertrand Nalpas; Nicolas Goossens; Lorenz Kuske; Beat Müllhaupt; Tillman Gerlach; Markus H Heim; Darius Moradpour; Andreas Cerny; Raffaele Malinverni; Stephan Regenass; Guenter Dollenmaier; Hans Hirsch; Gladys Martinetti; Meri Gorgiewski; Marc Bourlière; Thierry Poynard; Ioannis Theodorou; Laurent Abel; Stanislas Pol; Jean-François Dufour; Francesco Negro
Journal:  Hepatology       Date:  2011-12-16       Impact factor: 17.425

4.  Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus.

Authors:  Peter V Aka; Mark H Kuniholm; Ruth M Pfeiffer; Alan S Wang; Wei Tang; Sabrina Chen; Jacquie Astemborski; Michael Plankey; Maria C Villacres; Marion G Peters; Seema Desai; Eric C Seaberg; Brian R Edlin; Howard D Strickler; David L Thomas; Ludmila Prokunina-Olsson; Gerald B Sharp; Thomas R O'Brien
Journal:  J Infect Dis       Date:  2013-08-15       Impact factor: 5.226

5.  IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18.

Authors:  Weiguo Fan; Shiqi Xie; Xinhao Zhao; Nan Li; Chong Chang; Li Li; Ge Yu; Xiumei Chi; Yu Pan; Junqi Niu; Jin Zhong; Bing Sun
Journal:  J Gen Virol       Date:  2016-06-14       Impact factor: 3.891

6.  Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.

Authors:  Salvatore Petta; Luca Valenti; Antonino Tuttolomondo; Paola Dongiovanni; Rosaria Maria Pipitone; Calogero Cammà; Daniela Cabibi; Vito Di Marco; Anna Ludovica Fracanzani; Sara Badiali; Valerio Nobili; Silvia Fargion; Stefania Grimaudo; Antonio Craxì
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

7.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

8.  IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients.

Authors:  Melanie E Garrett; Manal F Abdelmalek; Allison Ashley-Koch; Michael A Hauser; Cynthia A Moylan; Herbert Pang; Anna Mae Diehl; Hans L Tillmann
Journal:  J Hepatol       Date:  2012-10-11       Impact factor: 25.083

Review 9.  Non-alcoholic fatty liver disease: the mist gradually clears.

Authors:  Nimantha Mark Wilfred de Alwis; Christopher Paul Day
Journal:  J Hepatol       Date:  2008-02-04       Impact factor: 25.083

10.  Racial differences in nonalcoholic fatty liver disease in the U.S. population.

Authors:  Andrea L C Schneider; Mariana Lazo; Elizabeth Selvin; Jeanne M Clark
Journal:  Obesity (Silver Spring)       Date:  2013-06-11       Impact factor: 5.002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.